Table 3.
Markers interactions | sBCG* | OR | Confidence interval (95%) | P | ||
---|---|---|---|---|---|---|
− | + | |||||
Salivary IgA | + | 14 | 47 | 1.56 | 0.59–4.09 | 0.362 |
− | 8 | 42 | ||||
Mitsuda* | ||||||
− | + | |||||
+ | 8 | 53 | 0.29 | 0.11–0.75 | 0.011 | |
− | 17 | 33 | ||||
Mitsuda/sBCG* | ||||||
− | + | |||||
+ | 2 | 41 | 0.29 | 0.05–1.61 | 0.15 | |
− | 5 | 30 |
Bold fonts were used to emphasize the significant values.
sBCG (−) = worse prognosis (0 cBCG) and (+) = better prognosis (1 and 2 sBCG).
Mitsuda (−) = worse prognosis (0–3 mm) and (+) = better prognosis (≥4 mm).
Mitsuda/sBCG (–) = worse prognosis (Mit < 4/sBCG-ID = 0) and (+) = better prognosis (Mitsuda ≥ 4/sBCG ≥ 1).